In the complex world of healthcare economics, few topics generate as much debate and interest as drug pricing. As healthcare […]
Value-Based Drug Pricing: A Promising Yet Challenging Approach to Healthcare Reform Read Post »
The Pharmaceutical Landscape: A Delicate Balance In the complex world of healthcare, few topics spark as much debate as the
The Cost Of A Cure: Patent Rights And Drug Prices Read Post »
In the complex and often controversial world of pharmaceutical pricing, a $37,000-a-year medicine is emerging as an unexpected model for
How a $37,000-a-year medicine sets a good model for drug pricing Read Post »
Three Big Mistakes Drug Companies Make in Recruiting New Employees In the fast-paced world of biopharmaceuticals, recruiting top talent is
3 big mistakes drug companies make in recruiting new employees Read Post »
The biopharmaceutical industry stands at a crossroads. The era of blockbuster drugs, once the lifeblood of big pharma, is waning.
As blockbuster drugs fizzle, biotech looks warily to the next big thing Read Post »
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food
By Dylan Scott, Posted with permission from STAT Mark Cuban has something to say about prescription drug prices. The billionaire
Some Biosimilars Are Just as Good as Some Pricey Biologics: A Game-Changer in Healthcare In the world of medicine, we’re
Some biosimilars are just as good as some pricey biologics Read Post »
Thank you for your interest in submitting a guest article! Submit your guest article here DrugPatentWatch is interested in sharing
Get fresh news and insights, drug patent expirations & more…
